Clinical trialNCT05052502CompletedInterventional

Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand

SponsorUniversity of California, San FranciscoEnrollment14,977Plasmodium Falciparum MalariaPlasmodium Vivax Malaria

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study assesses the effectiveness of reactive focal mass drug administration (rfMDA), targeting both village and forest working populations, compared to control for reducing the health promotion hospital-level (sub-district) incidence and prevalence of P. falciparum and P. vivax within five provinces in Thailand.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Adam Bennett, MA, PhD
University of California, San Francisco
Principal Investigator
clinicaltrials.gov ↗
Cheewanan Lertpiriyasuwat, MD
Ministry of Health, Thailand
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Thailand

Division of Vector Born Diseases, Ministry of Health
Bangkok, Thailand

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Nov 2020
Primary completion: 31 Mar 2022
Completion: 31 Mar 2022
Last update posted: 29 Apr 2026
Registered enrollment: 14,977
Registry id: NCT05052502

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.